Recombinant Vaccine Market Report

Global and Europe Recombinant Vaccine Market Professional Survey Report 2019

  • POSTDATE：Jun 21, 2020
  • PAGES：189
  • REPORT CODE：GMM576430
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Global Recombinant Vaccine market was valued at XX.0 million US$ in 2018, with the CAGR of 5.4%, this market is estimated to reach USD XX.0 million US$ in 2026.

    This report mainly elaborates on the segmentation, end-user, size, share, trend, future demand and leading players with respect to the Global and Europe Recombinant Vaccine market. Describe product range of Recombinant Vaccine, market overview, market opportunities, market drivers, limitations, PEST and SWOT analysis. Introducing market share, production, consumption, revenue, and growth of Global major regions from 2014-2019 and forecast to 2026.

    The report also provides a detailed analysis of the Europe Recombinant Vaccine market from 2014 to 2026 based on the product type and end-user. It provides a detailed overview of the market of the top 16 countries of Europe along with top companies' data analysis and product introductions of Europe Recombinant Vaccine market.

     

    By Player

    • Bharat Biotech

    • Green Cross Corporation

    • Protein Science Corporation

    • GlaxoSmithKline Plc

    • Novartis AG

    By Type

    • Subunit Recombinant Vaccines

    • Attenuated Recombinant Vaccines

    • Vector Recombinant Vaccines

    By End-User

    • Human

    • Animal

    By Region

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Netherlands

    • Portugal

    • Denmark

    • Finland

    • Iceland

    • Norway

    • Sweden

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Recombinant Vaccine Market

    • 1.3 Market Segment by Type

      • 1.3.1 Global Recombinant Vaccine Market Size and Growth Rate of Subunit Recombinant Vaccines from 2014 to 2026

      • 1.3.2 Global Recombinant Vaccine Market Size and Growth Rate of Attenuated Recombinant Vaccines from 2014 to 2026

      • 1.3.3 Global Recombinant Vaccine Market Size and Growth Rate of Vector Recombinant Vaccines from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Global Recombinant Vaccine Market Size and Growth Rate of Human from 2014 to 2026

      • 1.4.2 Global Recombinant Vaccine Market Size and Growth Rate of Animal from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 North America Recombinant Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Recombinant Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Recombinant Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA Recombinant Vaccine Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Recombinant Vaccine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Recombinant Vaccine by Major Types

      • 3.4.1 Recombinant Vaccine Market Size and Growth Rate of Subunit Recombinant Vaccines

      • 3.4.2 Recombinant Vaccine Market Size and Growth Rate of Attenuated Recombinant Vaccines

      • 3.4.3 Recombinant Vaccine Market Size and Growth Rate of Vector Recombinant Vaccines

    4 Segmentation of Recombinant Vaccine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Recombinant Vaccine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Recombinant Vaccine for Human

      • 4.4.2 Market Size and Growth Rate of Recombinant Vaccine for Animal

    5 Market Analysis by Major Regions

    • 5.1 Global Recombinant Vaccine Production Analysis by Top Regions

    • 5.2 Global Recombinant Vaccine Consumption Analysis by Top Regions

    • 5.3 Global Recombinant Vaccine Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Recombinant Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe Recombinant Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Recombinant Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA Recombinant Vaccine Production, Import, Consumption and Export Analysis

    6 Product Circulation of Recombinant Vaccine Market among Top Countries

    • 6.1 Top 5 Export Countries in Recombinant Vaccine Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Recombinant Vaccine Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Recombinant Vaccine Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Recombinant Vaccine Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Recombinant Vaccine Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Recombinant Vaccine Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America Recombinant Vaccine Landscape Analysis

    • 7.1 North America Recombinant Vaccine Landscape Analysis by Top Countries

      • 7.1.1 United States Recombinant Vaccine Market Volume and Growth Rate

      • 7.1.2 Canada Recombinant Vaccine Market Volume and Growth Rate

      • 7.1.3 Mexico Recombinant Vaccine Market Volume and Growth Rate

    8. Europe Recombinant Vaccine Landscape Analysis

    • 8.1 Europe Recombinant Vaccine Landscape Analysis by Major Types

    • 8.2 Europe Recombinant Vaccine Landscape Analysis by Major End-Users

    • 8.3 Europe Recombinant Vaccine Landscape Analysis by Top Countries

      • 8.3.1 Germany Recombinant Vaccine Market Volume and Growth Rate

      • 8.3.2 UK Recombinant Vaccine Market Volume and Growth Rate

      • 8.3.3 France Recombinant Vaccine Market Volume and Growth Rate

      • 8.3.4 Italy Recombinant Vaccine Market Volume and Growth Rate

      • 8.3.5 Spain Recombinant Vaccine Market Volume and Growth Rate

      • 8.3.6 Belgium Recombinant Vaccine Market Volume and Growth Rate

      • 8.3.7 Poland Recombinant Vaccine Market Volume and Growth Rate

      • 8.3.8 Russia Recombinant Vaccine Market Volume and Growth Rate

      • 8.3.9 Turkey Recombinant Vaccine Market Volume and Growth Rate

      • 8.3.10 Netherlands Recombinant Vaccine Market Volume and Growth Rate

      • 8.3.11 Portugal Recombinant Vaccine Market Volume and Growth Rate

      • 8.3.12 Denmark Recombinant Vaccine Market Volume and Growth Rate

      • 8.3.13 Finland Recombinant Vaccine Market Volume and Growth Rate

      • 8.3.14 Iceland Recombinant Vaccine Market Volume and Growth Rate

      • 8.3.15 Norway Recombinant Vaccine Market Volume and Growth Rate

      • 8.3.16 Sweden Recombinant Vaccine Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific Recombinant Vaccine Landscape Analysis

    • 9.1 Asia Pacific Recombinant Vaccine Landscape Analysis by Top Countries

      • 9.1.1 China Recombinant Vaccine Market Volume and Growth Rate

      • 9.1.2 Japan Recombinant Vaccine Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) Recombinant Vaccine Market Volume and Growth Rate

      • 9.1.4 India Recombinant Vaccine Market Volume and Growth Rate

      • 9.1.5 ASEAN Recombinant Vaccine Market Volume and Growth Rate

      • 9.1.6 South Korea Recombinant Vaccine Market Volume and Growth Rate

    10 LAMEA Recombinant Vaccine Landscape Analysis

    • 10.1 LAMEA Recombinant Vaccine Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries Recombinant Vaccine Market Volume and Growth Rate

      • 10.1.2 Brazil Recombinant Vaccine Market Volume and Growth Rate

      • 10.1.3 North Africa Recombinant Vaccine Market Volume and Growth Rate

      • 10.1.4 South Africa Recombinant Vaccine Market Volume and Growth Rate

      • 10.1.5 Argentina Recombinant Vaccine Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 Bharat Biotech

      • 11.1.1 Bharat Biotech Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Green Cross Corporation

      • 11.2.1 Green Cross Corporation Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Protein Science Corporation

      • 11.3.1 Protein Science Corporation Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 GlaxoSmithKline Plc

      • 11.4.1 GlaxoSmithKline Plc Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Novartis AG

      • 11.5.1 Novartis AG Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 113 Figures and 139 Tables)

    • Figure Product Picture

    • Figure Recombinant Vaccine Market Size and Growth Rate of Subunit Recombinant Vaccines from 2014 to 2026

    • Figure Recombinant Vaccine Market Size and Growth Rate of Attenuated Recombinant Vaccines from 2014 to 2026

    • Figure Recombinant Vaccine Market Size and Growth Rate of Vector Recombinant Vaccines from 2014 to 2026

    • Figure Global Recombinant Vaccine Market Size and Growth Rate of Human from 2014 to 2026

    • Figure Global Recombinant Vaccine Market Size and Growth Rate of Animal from 2014 to 2026

    • Figure North America Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure United States Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure UK Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure France Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure China Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Australia Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure India Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Recombinant Vaccine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Recombinant Vaccine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Recombinant Vaccine by Different Types from 2014 to 2026

    • Table Consumption Share of Recombinant Vaccine by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Subunit Recombinant Vaccines

    • Figure Market Size and Growth Rate of Attenuated Recombinant Vaccines

    • Figure Market Size and Growth Rate of Vector Recombinant Vaccines

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Recombinant Vaccine by Different End-Users from 2014 to 2026

    • Table Consumption Share of Recombinant Vaccine by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Human

    • Figure Market Size and Growth Rate of Animal

    • Table Global Recombinant Vaccine Production by Major Regions

    • Table Global Recombinant Vaccine Production Share by Major Regions

    • Table Global Recombinant Vaccine Consumption by Major Regions

    • Table Global Recombinant Vaccine Consumption Share by Major Regions

    • Table North America Recombinant Vaccine Production, Import, Consumption and Export Analysis

    • Table Europe Recombinant Vaccine Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Recombinant Vaccine Production, Import, Consumption and Export Analysis

    • Table LAMEA Recombinant Vaccine Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Recombinant Vaccine Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Recombinant Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Recombinant Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Recombinant Vaccine Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Recombinant Vaccine Consumption by Major Countries from 2014 to 2026

    • Table North America Recombinant Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Recombinant Vaccine Consumption Share by Major Countries in 2014

    • Figure North America Recombinant Vaccine Consumption Share by Major Countries in 2018

    • Figure North America Recombinant Vaccine Consumption Share by Major Countries in 2026

    • Figure United States Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Recombinant Vaccine Consumption by Types from 2014 to 2026

    • Table Europe Recombinant Vaccine Consumption Share by Types from 2014 to 2026

    • Table Europe Recombinant Vaccine Consumption by End-Users from 2014 to 2026

    • Table Europe Recombinant Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Europe Recombinant Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Europe Recombinant Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure France Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Recombinant Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Recombinant Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure China Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure India Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Recombinant Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Recombinant Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Bharat Biotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bharat Biotech

    • Figure Sales and Growth Rate Analysis of Bharat Biotech

    • Figure Revenue and Market Share Analysis of Bharat Biotech

    • Table Product and Service Introduction of Bharat Biotech

    • Table Company Profile and Development Status of Green Cross Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Green Cross Corporation

    • Figure Sales and Growth Rate Analysis of Green Cross Corporation

    • Figure Revenue and Market Share Analysis of Green Cross Corporation

    • Table Product and Service Introduction of Green Cross Corporation

    • Table Company Profile and Development Status of Protein Science Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Protein Science Corporation

    • Figure Sales and Growth Rate Analysis of Protein Science Corporation

    • Figure Revenue and Market Share Analysis of Protein Science Corporation

    • Table Product and Service Introduction of Protein Science Corporation

    • Table Company Profile and Development Status of GlaxoSmithKline Plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline Plc

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline Plc

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline Plc

    • Table Product and Service Introduction of GlaxoSmithKline Plc

    • Table Company Profile and Development Status of Novartis AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

    • Figure Sales and Growth Rate Analysis of Novartis AG

    • Figure Revenue and Market Share Analysis of Novartis AG

    • Table Product and Service Introduction of Novartis AG

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US